Characteristics of compared groups
| Group | Sex (F) | Age mean (SD) (years) | Disease duration mean (SD) (months) | Autoantibodies | MVR1-150 | Any valvular disease | Pulmonary hypertension1-151 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiolipin | β2GPI1-150 | ||||||||||||||
| IgG | IgM | ||||||||||||||
| pAPS1-150 | 22/29 | 41.4 (10.3) | 90 (86) | 26/29 | 15/29 | 17/29 | 14/29 | 14/29 | 4/29 | ||||||
| SLE/APS1-150 | 21/26 | 36.9 (13.0) | 115 (89) | 20/26 | 10/26 | 21/26 | 9/26 | 10/26 | 5/26 | ||||||
| SLE/aCL1-150 | 27/30 | 39.3 (12.6) | 85 (62) | 28/30 | 9/30 | 5/30 | 13/30 | 13/30 | 1/30 | ||||||
| SLE/no aCL1-150 | 41/43 | 38.0 (14.6) | 112 (109) | 0/43 | 0/43 | 0/43 | 8/43 | 11/43 | 4/43 | ||||||
| Normal | 31/36 | 38.3 (12.4) | ND | 0/36 | 0/36 | 0/36 | 0/36 | 0/36 | 0/36 | ||||||
↵1-150 β2 GPI = β2 glycoprotein I; MVR = mitral valve regurgitation; SLE = systemic lupus erythematosus; APS = antiphospholipid syndrome; pAPS = primary APS; SLE/APS: APS secondary to SLE; SLE/aCL = SLE with aCL (without APS); SLE/no aCL = SLE without aCL or APS; ND = no disease.
↵1-151 Pulmonary artery pressure above 30 mm Hg.